Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Partial nephrectomy has become the gold standard treatment for small renal masses. This study aimed to assess the impact of soft coagulation hemostasis on parenchymal volume reduction of the operated kidney after an open partial nephrectomy. We retrospectively reviewed 94 patients with small renal tumors who underwent open partial nephrectomy with soft-coagulation hemostasis at our institution. We measured the preoperative and postoperative renal volumes by computed tomography (CT) and calculated the renal volume reduction ratio as postoperative volume/preoperative volume. We performed multivariate analysis to identify the predictors of renal volume reduction. The median renal volume ratio was 0.75, and the median renal volume reduction rate was - 2.49 cm/month (IQR, - 3.33 to - 1.59). The RENAL score was inversely associated with ipsilateral renal volume reduction. In multivariate analysis, RENAL score, and tumor size were independent predictors of postoperative renal volume reduction. Soft coagulation hemostasis may influence the postoperative renal volume after partial nephrectomy, especially in patients with complex tumors.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11707299 | PMC |
| http://dx.doi.org/10.1038/s41598-025-85362-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A pediatric-onset case of chronic kidney disease caused by a novel sporadic variant and literature review.
Turk J Pediatr
September 2025
West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, Sichuan, China.
Background: The α-actinin-4 (ACTN4) gene encodes an actin-binding protein, which plays a crucial role in maintaining the structure and function of podocytes. Previous studies have confirmed that ACTN4 mutations can lead to focal segmental glomerulosclerosis-1 (FSGS1), a rare disease primarily manifesting in adolescence or adulthood, characterized by mild to moderate proteinuria, with some cases progressing slowly to end-stage renal disease.
Case Presentation: We report a 12.
Copeptin in the diagnosis and management of renal tubular disorders.
Pediatr Nephrol
September 2025
Pediatric Nephrology Department, Biobizkaia Health Research Institute, Cruces University Hospital, Barakaldo, Spain.
Copeptin, a stable glycopeptide derived from the precursor of arginine vasopressin (AVP), has emerged as a valuable surrogate biomarker for AVP due to its stability and ease of measurement. This narrative review explores the physiological role of copeptin, its utility as a diagnostic and prognostic biomarker in different kidney diseases, and its clinical relevance in renal tubular disorders. The clinical application of copeptin as a diagnostic biomarker is best established in the differential diagnosis of polyuria-polydipsia syndrome (PPS), distinguishing nephrogenic diabetes insipidus (NDI) from central diabetes insipidus (CDI) and primary polydipsia (PP).
View Article and Find Full Text PDFRegression equation for kidney function based on the ultrasonographic volumetry of the renal cortex.
J Nephrol
September 2025
Division of Gastroenterology and Nephrology, Faculty of Medicine, Tottori University, Nishi-cho 36-1, Yonago, Tottori, 683-8504, Japan.
Background: Chronic kidney disease (CKD) is a public health concern; kidney size correlates with kidney function, except in diabetic kidney disease (DKD), where the kidney enlarges, limiting morphological measurement applications in CKD management. However, cortical size changes in DKD along with CKD progression remain understudied. We investigated kidney morphology alterations in patients with and without diabetes and established a regression equation for kidney function incorporating morphological alterations.
View Article and Find Full Text PDFImpact of Vasospasm on the Effects of -butyl Cyanoacrylate Embolization in Swine Arteries.
Interv Radiol (Higashimatsuyama)
June 2025
Department of Radiology, Wakayama Medical University, Japan.
Unlabelled: -butyl cyanoacrylate is a liquid embolic material used to treat bleeding. Rebleeding may occur after -butyl cyanoacrylate embolization due to vasospasm and dilation of the embolized artery. However, the impact of vasospasm on -butyl cyanoacrylate embolization has not been fully investigated.
View Article and Find Full Text PDFTranscatheter Arterial Embolization with N-butyl-2-cyanoacrylate-Lipiodol for Downsizing of the Autosomal Dominant Polycystic Kidneys: A Case Report with Long-term Evaluation.
Interv Radiol (Higashimatsuyama)
June 2025
Department of Radiology, Oita University Faculty of Medicine, Japan.
This case report describes a 56-year-old woman with autosomal dominant polycystic kidney disease and chronic renal failure who underwent transcatheter arterial embolization with N-butyl-2-cyanoacrylate-Lipiodol before renal transplantation. Both kidneys were significantly enlarged, necessitating transcatheter arterial embolization to reduce renal volume and create space for transplantation. The right kidney volume decreased from 2520 to 1150 mL within 9 months after transcatheter arterial embolization, enabling successful transplantation.
View Article and Find Full Text PDF